Logo

BioMérieux: Jennifer Zinn

Jun 30, 2023

BioMérieux has appointed Jennifer Zinn as executive VP of clinical operations, effective Aug. 1. Zinn succeeds Pierre Boulud, who was recently appointed BioMérieux's CEO.

Zinn joined BioMérieux in October as general manager and head of clinical operations for North America and led the effort to prepare the US launch of the BioFire SpotFire, BioMérieux’s multiplex PCR system designed for decentralized point-of-care clinical settings. Previously, Zinn served as executive VP and head of diagnostics for North America at Siemens Healthineers, led commercial operations for North America at Roche Diagnostics, and worked in commercial operations at Ortho Clinical Diagnostics.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.